Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Jennifer Fokas, MD, and Minali Nigam, MD. [LISTEN TIME: 21 minutes]
|Videos|November 16, 2020
AUPN Leadership Minute Episode 3: Teaching Millennial Medical Students
Author(s)Rohit Das, MD, Mehmood Rashid, MD
Episode 3 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Mehmood Rashid, MD, of University of Toledo. [WATCH TIME: 4 minutes]
Advertisement
WATCH TIME: 4 minutes
AUPN's Leadership Minute is a brief, highly focused summary of practical advice for Chairs, Program Directors and other leaders in academic neurology, available as both mini-podcasts and in short form videos.
The goal of this program is to provide relevant and useful information in a modicum of time, designed to fit seamlessly into our very busy schedules.
Teaching Millennial Medical Students
What should medical educators know?
- Crave active engagement in learning.
- At ease with multimedia learning.
- Value choice and flexibility in learning.
- Prefer structured environments for learning.
- More open to feedback but prefer/expect continuous feedback.
- Accepting diversity and being interested in fairness.
- A larger gap between the expectation of achievement and the effort needed to achieve it.
How to effectively teach millennials?
- Technology should enhance learning and not replace it.
- Flipped classroom with pre-work before sessions.
- Recorded video or audio lectures (“podcast” style content).
- Simulation-based learning, game-based learning, etc.
- Add active content to your otherwise traditional lecture session.
- Set specific goals and provide an itemized list of tasks to be completed.
- Tell them who you are as a teacher.
Advertisement
Related to this article
Robert Bowser, PhD, chief scientific officer at Barrow Neurological Institute, recaps his ALS Nexus presentation on TDP-43 biology, the emerging therapeutic landscape, and how cryptic peptide biomarkers could reshape ALS clinical trial design.
KuangHua Guo, MD, PhD, sleep specialist at Northwestern Medicine, discussed emerging orexin agonist therapies and refined diagnostic approaches for hypersomnia.
FDA approval of apitegromab introduces a muscle-targeting approach to SMA treatment, with phase 3 data demonstrating motor-function benefit when added to existing SMN2-directed therapies.
The clinical neuropsychologist and assistant professor of medicine at the Icahn School of Medicine at Mount Sinai discussed the mechanisms behind brain fog from Long COVID and its potential links to Alzheimer risk.
A recent MS cohort study suggests that higher EBV nuclear antigen 1 antibody levels are associated with a lower risk of confirmed disability worsening, particularly among patients carrying both HLA-A02:01 and HLA-DRB115:01.
In honor of Muscular Dystrophy Awareness Month, held annually in September, NeurologyLive® looks back at the decade-long expansion of the DMD treatment landscape and the data that supports each approval.
Marketed as Fayuvi, the 1-time AAV9 gene therapy showed sustained cerebrospinal fluid heparan sulfate drops and developmental gains among pediatric patients with mucopolysaccharidosis type IIIA in prior studies.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves UX111, First Gene Therapy for Pediatric Sanfilippo Syndrome Type A
2
Exploring the Unmet Needs in CIDP
3
RIPK1 Inhibitor Fails to Slow Functional Decline in Phase 2 ALS Trial
4
Previewing Advancements in Hypersomnia Diagnosis and Treatment
5